Article
Colistin resistance mutations in phoQ can sensitize Klebsiella pneumoniae to IgM-mediated complement killing.
Scientific reports - 3 Aug 2023
van der Lans Sjors P A, Janet-Maitre Manon, Masson Frerich M, Walker Kimberly A, Doorduijn Dennis J, Janssen Axel B, van Schaik Willem, Attrée Ina, Rooijakkers Suzan H M, Bardoel Bart W
Abstract excerpt
Due to multi-drug resistance, physicians increasingly use the last-resort antibiotic colistin to treat infections with the Gram-negative bacterium Klebsiella pneumoniae. Unfortunately, K. pneumoniae can also develop colistin resistance. Interestingly, colistin resistance has dual effects on bacterial clearance by the immune system. While it increases resistance to antimicrobial peptides, colistin resistance has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
